We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00035581
Recruitment Status : Terminated
First Posted : May 6, 2002
Last Update Posted : April 17, 2013
Information provided by (Responsible Party):
Hemispherx Biopharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : September 2005
  Study Completion Date : September 2005